title: Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation.
abstract: Basal cell carcinoma (BCC) is the most common skin cancer worldwide. Surgical excision is considered to be the primary therapeutic modality wherever possible. For inoperable cases, 5% imiquimod seems to be a good alternative. We present two cases of nodular pigmented BCCs on the face in elderly women successfully treated with 5% imiquimod cream application resulting in complete clinical clearance of lesion as well as on histology and dermatoscopy. There was no recurrence of the lesion on 2 years follow-up for the first and 1.5 years for the second patient.
authors.affiliation: Department of Dermatology and STD, University College of Medical Sciences and GTB Hospital, University of Delhi, New Delhi, India.
authors.forename: Archana
authors.initials: A
authors.lastname: Singal
authors.affiliation: Department of Dermatology and STD, University College of Medical Sciences and GTB Hospital, University of Delhi, New Delhi, India.
authors.forename: Deepashree
authors.initials: D
authors.lastname: Daulatabad
authors.affiliation: Department of Dermatology and STD, University College of Medical Sciences and GTB Hospital, University of Delhi, New Delhi, India.
authors.forename: Deepika
authors.initials: D
authors.lastname: Pandhi
authors.affiliation: Department of Pathology, University College of Medical Sciences and GTB Hospital, University of Delhi, New Delhi, India.
authors.forename: V K
authors.initials: VK
authors.lastname: Arora
keywords: Basal cell carcinoma; dermatoscopy; imiquimod; immunomodulator